Education
About Us
Working with TipRanks
Follow Us
WALTERS GROUP Insider Profile
4 Followers
WALTERS GROUP, Ten Percent Owner at Zentalis Pharmaceuticals, holds 13.51M shares in Zentalis Pharmaceuticals (Ticker: ZNTL). Most recently, WALTERS GROUP Bought 6,459,973 shares of Zentalis Pharmaceuticals on Jan 08, 2026 for an estimated value of $7.75M.
WALTERS GROUP has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Ten Percent Owner
Roles that WALTERS GROUP holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by WALTERS GROUP
WALTERS GROUP's Trading History
List of latest transactions for each holding click on a transaction to see WALTERS GROUP's performance on stock
You May Also Like
WALTERS GROUP insider profile FAQ
What is the percentage of profitable transactions made by WALTERS GROUP?
The percentage of profitable transactions made by WALTERS GROUP is ―.
What is the average return per transaction made by WALTERS GROUP?
The average return per transaction made by WALTERS GROUP is ―.
What stocks does WALTERS GROUP hold?
WALTERS GROUP holds: ZNTL stocks.
What was WALTERS GROUP’s latest transaction?
WALTERS GROUP latest transaction was an Informative Buy of $7.75M.
What was WALTERS GROUP's most profitable transaction?
WALTERS GROUP’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is WALTERS GROUP's role in Zentalis Pharmaceuticals?
WALTERS GROUP's role in Zentalis Pharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.